Cargando…

Identification of microRNAs Targeting the Transporter Associated with Antigen Processing TAP1 in Melanoma

The underlying molecular mechanisms of the aberrant expression of components of the HLA class I antigen processing and presentation machinery (APM) in tumors leading to evasion from T cell-mediated immune surveillance could be due to posttranscriptional regulation mediated by microRNAs (miRs). So fa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lazaridou, Maria-Filothei, Massa, Chiara, Handke, Diana, Mueller, Anja, Friedrich, Michael, Subbarayan, Karthikeyan, Tretbar, Sandy, Dummer, Reinhard, Koelblinger, Peter, Seliger, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563967/ https://www.ncbi.nlm.nih.gov/pubmed/32825219 http://dx.doi.org/10.3390/jcm9092690

Ejemplares similares

Identification of miR-200a-5p targeting the peptide transporter TAP1 and its association with the clinical outcome of melanoma patients
por: Lazaridou, Maria-Filothei, et al.
Publicado: (2020)

Identification and characterization of novel CD274 (PD‐L1) regulating microRNAs and their functional relevance in melanoma
por: Vaxevanis, Christoforos K., et al.
Publicado: (2022)

Identification of a novel miR‐21‐3p/TGF‐β signaling‐driven immune escape via the MHC class I/biglycan axis in tumor cells
por: Subbarayan, Karthikeyan, et al.
Publicado: (2021)

Characterizing CD44 regulatory microRNAs as putative therapeutic agents in human melanoma
por: Fänder, Johannes, et al.
Publicado: (2019)

Distinct Molecular Mechanisms of Altered HLA Class II Expression in Malignant Melanoma
por: Meyer, Stefanie, et al.
Publicado: (2021)

Correlation of the tumor escape phenotype with loss of PRELP expression in melanoma
por: Schäfer, Helene, et al.
Publicado: (2023)

Role of signal transduction and microRNAs on the immunogenicity of melanoma cells
por: Meyer, Stefanie, et al.
Publicado: (2015)

Targeted treatment of advanced NRAS-mutated melanoma
por: Koelblinger, Peter, et al.
Publicado: (2017)

Development of encorafenib for BRAF-mutated advanced melanoma
por: Koelblinger, Peter, et al.
Publicado: (2018)

TGF-β inducible epithelial-to-mesenchymal transition in renal cell carcinoma
por: Tretbar, Sandy, et al.
Publicado: (2019)

Biglycan as a mediator of proinflammatory response and target for MDS and sAML therapy
por: Vaxevanis, Christoforos K., et al.
Publicado: (2022)

Biglycan as a potential regulator of tumorgenicity and immunogenicity in K-RAS-transformed cells
por: Subbarayan, Karthikeyan, et al.
Publicado: (2022)

Immune Interaction Map of Human SARS-CoV-2 Target Genes: Implications for Therapeutic Avenues
por: Subbarayan, Karthikeyan, et al.
Publicado: (2021)

Surrogate Antigen Processing Mediated by TAP-dependent Antigenic Peptide Secretion
por: Gabathuler, Reinhard, et al.
Publicado: (1998)

The role of cyclin D1 and Ki‐67 in the development and prognostication of thin melanoma
por: Kaufmann, Corina, et al.
Publicado: (2020)

MicroRNAs affecting the susceptibility of melanoma cells to CD8(+) T cell‐mediated cytolysis
por: Pane, Antonino A., et al.
Publicado: (2023)

Anticancer Activity of Natural and Semi-Synthetic Drimane and Coloratane Sesquiterpenoids
por: Beckmann, Lorenz, et al.
Publicado: (2022)

The Roles of MiRNAs (MicroRNAs) in Melanoma Immunotherapy
por: Dong, Linyinxue, et al.
Publicado: (2022)

Structure and Dynamics of Antigenic Peptides in Complex with TAP
por: Lehnert, Elisa, et al.
Publicado: (2017)

Epigenetic control of the ubiquitin carboxyl terminal hydrolase 1 in renal cell carcinoma
por: Seliger, Barbara, et al.
Publicado: (2009)

Long-term pegylated interferon-α and its potential in the treatment of melanoma
por: Dummer, Reinhard, et al.
Publicado: (2009)

Serum microRNAs as biomarkers for recurrence in melanoma
por: Friedman, Erica B, et al.
Publicado: (2012)

TEIPP peptides: exploration of unTAPped cancer antigens
por: Marijt, Koen A., et al.
Publicado: (2019)

Dissimilar Appearances Are Deceptive–Common microRNAs and Therapeutic Strategies in Liver Cancer and Melanoma
por: Linck-Paulus, Lisa, et al.
Publicado: (2020)

Recent Progress in the Diagnosis and Treatment of Melanoma and Other Skin Cancers
por: Pawlik, Laura, et al.
Publicado: (2023)

Interferon Alpha Signalling and Its Relevance for the Upregulatory Effect of Transporter Proteins Associated with Antigen Processing (TAP) in Patients with Malignant Melanoma
por: Heise, Ruth, et al.
Publicado: (2016)

Prognostic significance of deregulated microRNAs in uveal melanomas
por: Falzone, Luca, et al.
Publicado: (2019)

Identification of dysregulated microRNAs in canine malignant melanoma
por: Ushio, Norio, et al.
Publicado: (2019)

MicroRNAs in melanoma development and resistance to target therapy
por: Fattore, Luigi, et al.
Publicado: (2017)

A new B-Raf inhibitor combo for advanced melanoma
por: Barysch, Marjam-Jeanette, et al.
Publicado: (2018)

Hair Depigmentation and Hair Loss in Advanced Melanoma Treated with Combined Immunotherapy and Targeted Therapy
por: DIMITRIOU, Florentia, et al.
Publicado: (2020)

Interferons and Resistance Mechanisms in Tumors and Pathogen-Driven Diseases—Focus on the Major Histocompatibility Complex (MHC) Antigen Processing Pathway
por: Massa, Chiara, et al.
Publicado: (2023)

Regulation of Cancer Aggressive Features in Melanoma Cells by MicroRNAs
por: Greenberg, Eyal, et al.
Publicado: (2011)

Circulating microRNAs as Candidate Biomarkers for the Surveillance of Melanoma Patients
por: Behrmann, Iris, et al.
Publicado: (2015)

microRNAs and next generation sequencing for the prognosis of the metastatic melanoma
por: Pinto, Rosamaria, et al.
Publicado: (2015)

Bioinformatics analysis to identify the critical genes, microRNAs and long noncoding RNAs in melanoma
por: Zhang, Qian, et al.
Publicado: (2017)

Targeted therapy in melanoma – the role of BRAF, RAS and KIT mutations
por: Goldinger, Simone M., et al.
Publicado: (2013)

Combining talimogene laherparepvec with immunotherapies in melanoma and other solid tumors
por: Dummer, Reinhard, et al.
Publicado: (2017)

Using the TAP Component of the Antigen-Processing Machinery as a Molecular Adjuvant
por: Vitalis, Timothy Z, et al.
Publicado: (2005)

Targeting the coding sequence: opposing roles in regulating classical and non-classical MHC class I molecules by miR-16 and miR-744
por: Friedrich, Michael, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_o3gsd006m16jt1codhs15i77g8